Advancing Electrophysiology: Innovations, Challenges, and the Future of Arrhythmia Management.

COI Statement

Funding Support and Author Disclosures In the past 3 years, Dr Krumholz has received options for Element Science and Identifeye and payments from F-Prime for advisory roles; was a co-founder of and held equity in Hugo Health; is a co-founder of and holds equity in Refactor Health and ENSIGHT-AI; and is associated with research contracts through Yale University from Janssen, Kenvue, Novartis, and Pfizer.